its saving grace is that in the clinical trial patients on tobi were probably taking it two times a day and in the real world there is a lot of non compliance
so the arikace was probably better than tobi once a day.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.